Cellectis Logo.png
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
16 mai 2024 16h30 HE | Cellectis Inc.
(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS, 16 mai 2024 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Growth ISIN code: FR0010425595 DateNombre total...
Nanobiotix logo.jpg
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social
16 mai 2024 16h15 HE | Nanobiotix S.A.
Conformément aux articles L.233-8 II du Code de commerce et 223-16 du Règlement Général de l’Autorité des Marchés Financiers PARIS, 16 mai 2024 (GLOBE NEWSWIRE) -- Place de cotation : Euronext...
Nanobiotix logo.jpg
Voting Rights and Shares Capital of the Company
16 mai 2024 16h15 HE | Nanobiotix S.A.
In accordance with Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers) PARIS, May 16,...
New IDEX Logo 2018 - grey font - white background.png
IDEX Biometrics ASA - Key information relating to possible subsequent offering/repair issue
15 mai 2024 18h18 HE | IDEX BIOMETRICS ASA
Oslo, 15 May 2024 Reference is made to the stock exchange notice from IDEX Biometrics ASA ("IDEX" or the "Company") on 15 May 2024 regarding a private placement of shares in the Company raising...
New IDEX Logo 2018 - grey font - white background.png
Grant of Incentive Subscription Rights in IDEX Biometrics 15 May 2024
15 mai 2024 17h44 HE | IDEX BIOMETRICS ASA
The board of directors of IDEX Biometrics ASA resolved on 15 May 2024 to issue 40,900 incentive subscription rights to a new individual contractor in the IDEX Biometrics group. The grant was made...
T2Biosystems_Logo.jpg
T2 Biosystems Announces CRG’s Conversion from Preferred Stock to Common Stock
14 mai 2024 17h00 HE | T2 Biosystems, Inc.
LEXINGTON, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes,...
HFP logo.png
Results of Voting for Directors at Annual General Shareholders’ Meeting
14 mai 2024 17h00 HE | Helios Fairfax Partners Corporation
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, May 14, 2024 (GLOBE NEWSWIRE) -- Helios Fairfax Partners Corporation (TSX: HFPC.U) (“HFP”)...
eQ Oyj:n osakemäärä
eQ Oyj:n osakemäärä on lisääntynyt optio-oikeuksilla merkityillä osakkeilla
14 mai 2024 01h30 HE | eQ Oyj
eQ Oyj Osakkeiden kokonaismäärä ja äänimäärä14.5.2024, klo 8:30 eQ Oyj:n optio-ohjelman 2018 mukaisilla optio-oikeuksilla on merkitty yhteensä 182 500 uutta yhtiön osaketta. Merkintähinta...
Number of Shares in
Number of Shares in eQ Plc has Increased through Subscription with Stock Options
14 mai 2024 01h30 HE | eQ Oyj
eQ Plc Total Number of Voting Rights and Capital14 May 2024, at 8.30 a.m. A total number of 182,500 new shares in eQ Plc have been subscribed for with stock options of eQ Plc’s option scheme...
Déclaration au titre
Déclaration au titre de l’article L. 233-8 II du Code de Commerce et de l’article 223-16 du Règlement général de l’Autorité des marchés financiers
13 mai 2024 12h10 HE | SCOR
Information13 mai 2024 Déclaration au titre de l’article L. 233-8 II du Code de Commerce et de l’article 223-16 du Règlement général de l’Autorité des marchés financiers Information relative au...